$70.65
0.220.31%
Pre-Market: 7:13 AM EDT
15 minutes delayed
DexCom reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DexCom using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $0.43 | $0.39 | 10.3 % |
Mar 2024 | 2024-04-25 | $0.32 | $0.27 | 18.5 % |
Dec 2023 | 2024-02-08 | $0.50 | $0.43 | 16.3 % |
Sep 2023 | 2023-10-26 | $0.50 | $0.34 | 47.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $1.00B | $1.04B | -3.46 % |
Mar 2024 | 2024-04-25 | $921.00M | $909.24M | 1.29 % |
Dec 2023 | 2024-02-08 | $1.03B | $1.02B | 1.42 % |
Sep 2023 | 2023-10-26 | $975.00M | $939.24M | 3.81 % |
DexCom (DXCM) is scheduled to report earnings on October 24, 2024. The last reported earnings were for reported on July 25, 2024 for Q2.
The Actual EPS was $0.43, which beat the estimate of $0.39.
The Actual Revenue was $1B, which missed the estimate of $1B.
Browse earnings estimates, EPS, and revenue on all stocks.